Arthex Biotech
Clinical stage treatment for Myotonic Dystrophy Type 1
2
Funding Rounds
$50.9m
Money raised
Overview
Clinical stage treatment for Myotonic Dystrophy Type 1
-
Website:
- Headquarters: Valencia
- Social accounts:
Funding
Funding series
Funding Series Analysis
The company Arthex Biotech has raised a total of $50.9m in funding over 2 rounds.
Key Insights:
- ARTHEx Biotech May 2023 Series B Funding Round: $46m
- Arthex Biotech , July 2020: $4.9m
ARTHEx Biotech May 2023 Series B Funding Round
$46m
Arthex Biotech , July 2020
$4.9m
Industries
Arthex Biotech is active in the following industries: